Have a personal or library account? Click to login
Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line Cover

Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line

Acta Pharmaceutica
Volume 63 (2013): Issue 4 (December 2013)
By: Tiam Feridooni,  Chris Mac Donald,  Di Shao,  Pollen Yeung and  Remigius U. Agu  
Open Access
|Dec 2013

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/acph-2013-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 493 - 503
Published on: Dec 31, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
rat myoblast (H9c2),
cytoprotection,
dexrazoxane,
doxorubicin,
diltiazem,
irinotecan
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Tiam Feridooni, Chris Mac Donald, Di Shao, Pollen Yeung, Remigius U. Agu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Previous articleVolume 63 (2013): Issue 4 (December 2013)Next article